Park Ha Biological Technology Co., Ltd. (BYAH) - Net Assets
Based on the latest financial reports, Park Ha Biological Technology Co., Ltd. (BYAH) has net assets worth $4.25 Million USD as of April 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($5.83 Million) and total liabilities ($1.58 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read Park Ha Biological Technology Co., Ltd. debt and liabilities for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.25 Million |
| % of Total Assets | 72.88% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 262.49 |
Park Ha Biological Technology Co., Ltd. - Net Assets Trend (2021–2024)
This chart illustrates how Park Ha Biological Technology Co., Ltd.'s net assets have evolved over time, based on quarterly financial data. Also explore Park Ha Biological Technology Co., Ltd. total assets for the complete picture of this company's asset base.
Annual Net Assets for Park Ha Biological Technology Co., Ltd. (2021–2024)
The table below shows the annual net assets of Park Ha Biological Technology Co., Ltd. from 2021 to 2024. For live valuation and market cap data, see Park Ha Biological Technology Co., Ltd. (BYAH) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-10-31 | $1.51 Million | +48.75% |
| 2023-10-31 | $1.01 Million | +573.74% |
| 2022-10-31 | $150.28K | +125.99% |
| 2021-10-31 | $-578.18K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Park Ha Biological Technology Co., Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 138993900.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (October 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $271.79K | 18.05% |
| Common Stock | $500.00 | 0.03% |
| Other Comprehensive Income | $72.59K | 4.82% |
| Other Components | $1.16 Million | 77.10% |
| Total Equity | $1.51 Million | 100.00% |
Park Ha Biological Technology Co., Ltd. Competitors by Market Cap
The table below lists competitors of Park Ha Biological Technology Co., Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Medalist Diversified Reit Inc
NASDAQ:MDRR
|
$12.70 Million |
|
Yummy Town Cayman Holdings
TWO:2726
|
$12.71 Million |
|
Gauzy Ltd. Ordinary Shares
NASDAQ:GAUZ
|
$12.71 Million |
|
Cyabra, Inc. Common Stock
NASDAQ:CYAB
|
$12.71 Million |
|
WISDOM ED.INTL.HLD.HD-01
F:5Q4
|
$12.68 Million |
|
Société Hôtelière et Immobilière de Nice S.A
PA:MLHIN
|
$12.67 Million |
|
Rail Vision Ltd. Ordinary Share
NASDAQ:RVSN
|
$12.67 Million |
|
Good Times Restaurants Inc
NASDAQ:GTIM
|
$12.67 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Park Ha Biological Technology Co., Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,012,473 to 1,506,085, a change of 493,612 (48.8%).
- Net income of 478,561 contributed positively to equity growth.
- New share issuances of 500 increased equity.
- Other comprehensive income increased equity by 116,091.
- Other factors decreased equity by 101,540.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $478.56K | +31.78% |
| Share Issuances | $500.00 | +0.03% |
| Other Comprehensive Income | $116.09K | +7.71% |
| Other Changes | $-101.54K | -6.74% |
| Total Change | $- | 48.75% |
Book Value vs Market Value Analysis
This analysis compares Park Ha Biological Technology Co., Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 19.66x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-10-31 | $-0.02 | $1.13 | x |
| 2022-10-31 | $0.01 | $1.13 | x |
| 2023-10-31 | $0.04 | $1.13 | x |
| 2024-10-31 | $0.06 | $1.13 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Park Ha Biological Technology Co., Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 31.78%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 20.09%
- • Asset Turnover: 0.77x
- • Equity Multiplier: 2.05x
- Recent ROE (31.78%) is below the historical average (60.81%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 0.00% | -52.09% | 1.57x | 0.00x | $-427.14K |
| 2022 | 127.30% | 9.97% | 0.76x | 16.76x | $176.27K |
| 2023 | 84.15% | 34.65% | 1.09x | 2.24x | $750.79K |
| 2024 | 31.78% | 20.09% | 0.77x | 2.05x | $327.95K |
Industry Comparison
This section compares Park Ha Biological Technology Co., Ltd.'s net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $1,515,458,419
- Average return on equity (ROE) among peers: -535.31%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Park Ha Biological Technology Co., Ltd. (BYAH) | $4.25 Million | 0.00% | 0.37x | $12.69 Million |
| Acme United Corporation (ACU) | $6.50 Million | -49.23% | 3.20x | $159.26 Million |
| Bruush Oral Care Inc. (BRSHF) | $163.14K | -5449.60% | 11.70x | $10.10K |
| Church & Dwight Company Inc (CHD) | $2.04 Billion | 15.17% | 0.53x | $22.73 Billion |
| Colgate-Palmolive Company (CL) | $243.00 Million | 832.92% | 51.16x | $70.34 Billion |
| The Clorox Company (CLX) | $297.00 Million | 218.18% | 14.21x | $10.53 Billion |
| Coty Inc (COTY) | $9.87 Billion | -4.28% | 1.28x | $1.95 Billion |
| Carmell Therapeutics Corporation (CTCX) | $-37.79 Million | 0.00% | 0.00x | $4.61 Million |
| Big Tree Cloud Holdings Limited Ordinary Shares (DSY) | $453.17K | -417.72% | 4.36x | $19.52 Million |
| Estee Lauder Companies Inc (EL) | $1.22 Billion | 36.81% | 2.38x | $19.60 Billion |
About Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells produ… Read more